Author details

Full Name

Howard L Weiner

Affiliation

ORCID

Career Start Year

1971

Papers

830

H Index

134

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36456723	Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping.	Cerebellum	2024
36976711	Assessment of Microglial Activation in Alzheimer Disease Using 18 F-PBR06 PET.		2023
36376097	Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis.	Neurology: Neuroimmunology and NeuroInflammation	2023
36434283	Vagus nerve stimulator revision in pediatric epilepsy patients: a technical note and case series.	Child's Nervous System	2023
36448331	Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients.	Multiple Sclerosis Journal	2023
37604135	Advances in Imaging Modalities for Pediatric Brain and Spinal Cord Tumors.		2023
36517974	Multi-Center Validation of the McGovern Pediatric Blunt Cerebrovascular Injury Screening Score.		2023
36898277	Innovation and clinical progress in oral tolerance.		2023
37463881	VÎ³1 and VÎ³4 gamma-delta T cells play opposing roles in the immunopathology of traumatic brain injury in males.	Nat Commun	2023
37271658	Monocyte regulation by gut microbial signals.		2023
37461671	Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis.	medRxiv	2023
37264432	Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10Â years: a cohort study.		2023
36881624	Nasal administration of anti-CD3 mAb (Foralumab) downregulates <i>NKG7</i> and increases <i>TGFB1</i> and <i>GIMAP7</i> expression in T cells in subjects with COVID-19.	Proc Natl Acad Sci U S A	2023
36814316	Gamma-delta T cells modulate the microbiota and fecal micro-RNAs to maintain mucosal tolerance.		2023
36637274	Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical Approach.	Neurosurgery	2023
36700739	Pediatric Vagus Nerve Stimulation: Case Series Outcomes and Future Directions.		2023
37254147	miRNA 548a-3p as biomarker of NEDA-3 at 2Â years in multiple sclerosis patients treated with fingolimod.		2023
37062282	An Initial Experience of Completion Hemispherotomy via Magnetic Resonance-Guided Laser Interstitial Therapy.	Stereotact Funct Neurosurg	2023
37001498	Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting.		2023
37060852	Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.		2023
37057191	Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.	Mult Scler J Exp Transl Clin	2023
37302216	Responsive Neurostimulation for the Treatment of Children With Drug-Resistant Epilepsy in Tuberous Sclerosis Complex.	Pediatr Neurol	2023
37175706	Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis.	Int J Mol Sci	2023
36787706	Behavioral Improvements following Lesion Resection for Pediatric Epilepsy: Pediatric Psychosurgery?		2023
34806979	Knowledge gaps for functional outcomes after multilobar resective and disconnective pediatric epilepsy surgery: Conference Proceedings of the Patient-Centered Stakeholder Meeting 2019.	Epileptic Disorders	2022
35461057	Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis.	Multiple Sclerosis and Related Disorders	2022
35396292	Connectomic profiling and Vagus nerve stimulation Outcomes Study (CONNECTiVOS): a prospective observational protocol to identify biomarkers of seizure response in children and youth.	BMJ Open	2022
35395272	Oral tolerance: an updated review.	Immunology Letters	2022
35590190	Targeting Epstein-Barr virus to treat MS.	Med	2022
35901680	Natural history of posterior fetal cephaloceles and incidence of progressive cephalocele herniation.	J Neurosurg Pediatr	2022
35953266	Younger age at multiple sclerosis onset is associated with worse outcomes at age 50.	Journal of Neurology, Neurosurgery and Psychiatry	2022
35952457	Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.	Mult Scler Relat Disord	2022
35820822	Comparison of dimethyl fumarate and interferon outcomes in an MS cohort.	BMC Neurology	2022
35816952	Estimating the association between physical activity and health-related quality of life in individuals with multiple sclerosis.	Multiple Sclerosis and Related Disorders	2022
35429009	Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis.	Annals of Neurology	2022
35729081	Limited utility of structural MRI to identify the epileptogenic zone in young children with tuberous sclerosis.	J Neuroimaging	2022
35672799	Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets.		2022
36056406	CD8 T cells in neurodegeneration: friend or foe?	Molecular Neurodegeneration	2022
35535827	Introduction. Evolving perspectives on the intersection between neurosurgery and neurocutaneous disorders.	Neurosurgical Focus	2022
36449422	Infantile and Childhood Hydrocephalus.	New England Journal of Medicine	2022
36253847	Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.	Microbiome	2022
35598587	Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities.	Pediatr Neurol	2022
36505477	Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects.	Front Immunol	2022
36548255	Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.	PLoS One	2022
35298438	microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.	Journal of Clinical Investigation	2022
35272713	The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis.	Microbiome	2022
35035990	Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.	Mult Scler J Exp Transl Clin	2022
34731297	Maximizing the subtonsillar transcerebellomedullary approach to suprasellar cistern: how I do it.	Acta Neurochirurgica	2022
34783972	Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis.	Quality of Life Research	2022
35158446	Temporal trends of multiple sclerosis disease activity: Electronic health records indicators.	Mult Scler Relat Disord	2022